This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hollenberg, N. K Search for Related Content PubMed PubMed Citation Articles by Hollenberg, N. K Pubmed/NCBI databases Substance via MeSH Social Bookmarking                         What's this?

Spotlight on Renin

Therapeutic opportunities for renin inhibitors

Departments of Medicine and Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA

References

• Skeggs LT, Kahn JR, Lentz KE, Shumway NP Preparation, purification, and amino acid sequence of a polypeptide renin substrate. J Exp Med 1957;106:439-53.[Abstract]
• Flather MD, Yusuf S., Kober L. et al. Long-term ACEinhibitor therapy in patients with heart failure or left ventricular dysfunction: a systematic overview of data from individual patients. ACE inhibitor Myocardial Infarction Collaborative Group. Lancet 2000;355:1575-81.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: Systematic overview of individual data from 100,000 patients in randomized trials. Circulation 1998;97:2202-12.[Abstract/Free Full Text]
• Lee VC, Rhew DC, Dylan M., Badamgarav E., Braunstein GD, Weingarten SR Meta analysis: angiotensin receptor blockers in chronic heart failure and high risk acute myocardial analysis: angiotensin receptor blockers in chronic heart failure and high risk acute myocardial infarction. Ann Intern Med 2004;141:693-704.[Abstract/Free Full Text]
• Lewis EJ, Hunsicker LG, Bain RP, Rohde RD The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993;329:1456-62.[Abstract/Free Full Text]
• Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-60.[Abstract/Free Full Text]
• Brenner BM, Cooper ME, de Zeeuw D. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-9.[Abstract/Free Full Text]
• The GISEN Group. Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, nondiabetic nephropathy. Lancet 1997;349:1857-63.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:45-53.
• Navar GL, Harrison-Bernard LM, Imig JD, Mitchell KD Renal actions of angiotensin II and AT1 receptors. In: Angiotensin II Receptor Antagonists, edited by Epstein M, Brunner HR, Philadelphia, Hanley & Belfus, 2001, pp. 190.
• Fisher NDL, Hollenberg NK Renin Inhibition: What are the Therapeutic Opportunties. J Am Soc Nephrol 2005;16:592-9.[Abstract/Free Full Text]
• Fisher NDL, Hollenberg NK Is there a future for renin inhibitors? Expert Opin Investig Drugs 2001;10:417-26.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ondetti MA Design of specific inhibitors of angiotensin converting enzyme: New class of orally active antihypertensive agents. Science 1977;196:441-4.[Abstract/Free Full Text]
• Kleinert HD, Stein HH Specific renin inhibitors: Concepts and prospects. In: Hypertension, Pathophysiology, Diagnosis and Management, Vol. 2: Laragh JH, Brenner BM (eds), New York, Raven Press;1995,pp.3065-77.
• Nussberger J., Wuerzner G., Jensen C., Brunner HR Angiotensin II suppression in humans by the orally active renin inhibitor aliskiren (SPP100). Comparison with
• enalapril. Hypertension 2002;39:e1-e8. 16. Stanton A., Jensen C., Nussberger J., O'Brien E. Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren. Hypertension 2003;42:1-7.[Abstract/Free Full Text]
• Skinner SL The pathophysiology of prorenin. In: The ReninAngiotensin System, edited by Ian J, Robertson S, Nicholls MG, New York, Gower Medical Publishing; 1993, pp.7.1-11.
• Luetscher JA, Kraemer FB, Wilson DM Prorenin and vascular complications of diabetes. Am J Hypertens 1989;2:382-6.[Web of Science][Medline] [Order article via Infotrieve]
• Yoshida H. A study on inactive renin in the plasma of patients with diabetes mellitus. Hokkaido Igaku Zasshi. Hokkaido J Med Sci 1989;64:232-42.
• Franken AAM, Derkx FHM, Man in't Veld AJ etal. High plasma prorenin in diabetes mellitus and its correlation with some complications. J Clin EndocrinolMetab 1990;71: 1008-15.
• Wilson D., Luetscher JA Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med 1990;323:1101-06.[Abstract]
• Danser AHJ, van den Dorpel MA, Deinum J. et al. Renin, prorenin and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endcrinol Metab 1989;68:160-7.[Abstract/Free Full Text]
• Deinum J., Derkx FHM, Danser AHJ, Schalekamp Madh. Identification and quantification of renin and prorenin in the bovine eye. Endocrinology 1990;126:1673-82.[Abstract/Free Full Text]
• Derkx FHM. Human prorenin [Thesis], Rotterdam, Erasmus University of Rotterdam, 1987.
• Misbin I., Grant MB, Pecker MS, Atlas SA Elevated levels of plasma prorenin (inactive renin) in diabetic and nondiabetic patients with autonomic dysfunction. J Clin Endocrinol Metab 1987;64:964-8.[Abstract/Free Full Text]
• Wood JM, Stanton JL, Hofbauer KG Inhibitors of renin as potential therapeutic agents. J Enzyme Inhib 1987;1:169-85.[Medline] [Order article via Infotrieve]
• Nguyen G., Delarue F., Berrou J., Rondeau E., Sraer JD Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int 1996;50:1897-903.[Web of Science][Medline] [Order article via Infotrieve]
• Neutel JM, Luther RR, Boger RS, Weber MA Immediate blood pressure effects of the renin inhibitor enalkiren and the ACE inhibitor enalaprilat. Am Heart J 1991;122:1094-100.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Kiowski W., Linder L., Kleinbloesem C., Van Brummelen P., Buhler FR Blood pressure control of the renin-angiotensin system in normotensive subjects. Circulation 2002;85:1-8.
• Fisher NDL, Allan D., Kifor I., Gaboury CL, Williams GH, Moore TJ, Hollenberg NK Responses to converting enzyme and renin inhibition: Role of angiotensin II in humans. Hypertension 1994;23:44-51.[Abstract/Free Full Text]
• Fisher NDL, Hollenberg NK Renal vascular responses to renin inhibition with zankiren in men. Clin Pharmacol Ther 1995;57:342-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 6, No. 2, 107-109 (2005)
DOI: 10.3317/jraas.2005.008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hollenberg, N. K Search for Related Content PubMed PubMed Citation Articles by Hollenberg, N. K Pubmed/NCBI databases Substance via MeSH Social Bookmarking                         What's this?